Clinical trial of Vitamin D2 vs D3 supplementation in critically ill pediatric burn patients

Journal of Parenteral and Enteral Nutrition

Volumn 41, Issue 3, 2017, Pages 412-421

  Gottschlich, Michele M ^a,b   Mayes, Theresa ^a,c   Khoury, Jane ^c   Kagan, Richard J ^a,b  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

burn injury; pediatrics; Vitamin D

Indexed keywords

25 HYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; ANTIBIOTIC AGENT; CALCIFEDIOL; CALCITRIOL; COLECALCIFEROL; ERGOCALCIFEROL; INSULIN; OXANDROLONE; PARATHYROID HORMONE; BIOLOGICAL MARKER; VITAMIN;

ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; BODY SURFACE; BONE DENSITY; BONE MINERAL; BURN; BURN PATIENT; CHILD; CHILD HEALTH CARE; CLINICAL OUTCOME; CLINICAL PROTOCOL; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DENSITOMETRY; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; ELECTROCHEMILUMINESCENCE; ENTERIC FEEDING; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFANT; KELOID; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PHYSIOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; SCAR FORMATION; SEPSIS; SKIN TRANSPLANTATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WOUND HEALING; BLOOD; CRITICAL ILLNESS; DIETARY SUPPLEMENT; PRESCHOOL CHILD; PROSPECTIVE STUDY; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

ADOLESCENT; BIOMARKERS; BURNS; CHILD; CHILD, PRESCHOOL; CHOLECALCIFEROL; CRITICAL ILLNESS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ERGOCALCIFEROLS; FEMALE; HUMANS; INFANT; MALE; PARATHYROID HORMONE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VITAMIN D DEFICIENCY; VITAMINS;

EID: 85019048607     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607115587948     Document Type: Article

References (63)

1. Klein GL, Langman CB, Herndon DN,. Vitamin D depletion following burns in children: a possible factor in postburn osteopenia. J Trauma. 2002; 52: 346-350.
2. Wray C, Mayes T, Khoury J, Warden G, Gottschlich M,. Metabolic effects of vitamin D on serum calcium, magnesium, and phosphorus in pediatric burn patients. J Burn Care Rehab. 2002; 23: 416-423.
3. Gottschlich MM, Mayes T, Khoury J, Warden GD,. Hypovitaminosis D in acutely injured pediatric burn patients. J Am Diet Assoc. 2004; 104: 931-941.
4. Mayes T, Gottschlich MM, James L, Kagan RJ,. Serum vitamin D is inversely related to exogenous insulin requirement following burn injury. J Burn Care Rehabil. 2005; 26: S141.
5. Rousseau AF, Damas P, Ledoux D, Cavalier E,. Effect of cholecalciferol recommended daily allowances on vitamin D status and fibroblast growth factor-23: an observational study in acute burn patients. Burns. 2014; 40: 865-870.
6. Klein GL, Herndon DN, Chen TC, Kulp G, Holick MF,. Standard multivitamin supplementation does not improve vitamin D insufficiency after burns. J Bone Miner Metab. 2009; 27: 502-506.
7. Gottschlich M, Mayes T, Allgeier C, Khoury J, Kagan RJ,. Prospective evaluation of vitamin D status in children during rehabilitation. J Burn Care Res. 2007; 28: S157.
8. Klein GL, Chen TC, Holick MF, et al. Synthesis of vitamin D in skin after burns. Lancet. 2004; 363: 291-292.
9. Gottschlich MM, Sethuraman SA, Allgeier C, et al. Vitamin D biomarkers associated with abnormal scar formation. J Burn Care Res. In press.
10. Mayes T, Gottschlich MM, Khoury J, Kagan RJ,. An investigation of bone health subsequent to vitamin D supplementation in children following burn injury. Nutr Clin Pract. In press.
11. National Institutes of Health. Health professional fact sheet: vitamin D. http://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/. Accessed May 11, 2015.
12. Golden NH, Abrams SA, Committee on Nutrition. Optimizing bone health in children and adolescents. Pediatrics. 2014; 134: 1229-1243.
13. Artaza JN, Sirad F, Ferrini MG, Norris KC,. 1,25(OH)2 vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells. J Steroid Biochem Mol Biol. 2010; 119: 73-83.
14. Piemonti L, Monti P, Sironi M, et al. Vitamin D3 affects differentiation, maturation and function of human monocyte-derived dendritic cells. J Immunol. 2000; 164: 4443-4451.
15. Gottschlich MM,. Fat soluble vitamins in wound healing. In: Molnar JA, ed. Nutrition and Wound Healing. Boca Raton, FL: CRC; 2007: 149-171.
16. Gamady A, Koren R, Ron D, Liberman UA, Ravid A,. Vitamin D enhances mitogenesis mediated by keratinocyte growth factor receptor in keratinocytes. J Cell Biochem. 2003; 89: 440-449.
17. Muehleisen B, Bikle DD, Aguilera C, et al. PTH/PTHrP and vitamin D control antimicrobial peptide expression and susceptibility to bacterial skin infection. Sci Transl Med. 2012; 4: 1-8.
18. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R,. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract. 2003; 57: 258-261.
19. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham N,. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance. Diabetes. 2008; 57: 2619-2625.
20. Asemi Z, Hashemi T, Karamali M, Samimi M, Esmaillzadeh A,. Effects of vitamin D supplementation on glucose metabolism, lipid concentrations, inflammation, and oxidative stress in gestational diabetes: a double-blind randomized controlled clinical trial. Am J Clin Nutr. 2013; 98: 1425-1432.
21. Belenchia AM, Tosh AK, Hillman LS, Peterson CA,. Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr. 2013; 97: 774-781.
22. Teingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G,. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA. 2005; 294: 2336-2341.
23. Need AG, Horowitz M, Morris HA, Nordin BEC,. Vitamin D status: effects on parathyroid hormone and 1,25-dihydroxyvitamin D in postmenopausal women. Am J Clin Nutr. 2000; 71: 1577-1581.
24. Chiu KC, Chu A, Go VL, Saad MF,. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004; 79: 820-825.
25. Wilkinson RJ, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet. 2000; 355: 618-621.
26. Cetinkaya M, Cekmez F, Buyukkale G, et al. Lower vitamin D levels are associated with increased risk of early-onset neonatal sepsis in term infants. J Perinatol. 2015; 35 (1): 39-45.
27. Peric M, Koglin S, Kim SM, et al. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J Immunol. 2008; 181: 8504-8512.
28. Lagishetty V, Liu NQ, Hewison M,. Vitamin D metabolism and innate immunity. Mol Cell Endocrinol. 2001; 347: 97-105.
29. Kagan RJ,. Burn Service Survival Guide. 9th ed. Cincinnati, OH: Shriners Hospitals for Children; 2014.
30. Jenkins ME, Gottschlich MM, Baumer T, Khoury J, Warden GD,. Enteral feeding during operative procedures. J Burn Care Rehab. 1994; 15: 199-205.
31. Mayes T, Gottschlich MM, Warden GD,. Clinical nutrition protocols for continuous quality improvement in outcome. J Burn Care Rehab. 1997; 18: 365-368.
32. Gottschlich MM, Jenkins M, Warden GD, Baumer T, Snook JT, Alexander JW,. Differential effects of three enteral regimens on selected outcome parameters in burn patients. JPEN J Parent Enteral Nutr. 1990; 14: 225-236.
33. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2010.
34. Caton NL, McGill D, Stewart KJ,. Is the target of 1 day length of stay per 1% total body surface area burned actually being achieved? Int J Burns Trauma. 2014; 4: 25-30.
35. Houghton LA, Vieth R,. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr. 2006; 84: 694-697.
36. Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012; 95: 1357-1364.
37. Lehmann U, Hirche F, Stangl GI, Hinz K, Westphal S, Dierkes J,. Bioavailability of vitamin D2 and D3 in healthy volunteers, a randomized placebo-controlled trial. J Clin Endocrinol Metab. 2013; 98: 4339-4345.
38. 3 in humans. J Clin Endocrinol Metab. 2013; 89: 5387-5391.
39. 2 in humans. J Clin Endocinol Metab. 2010; 96: E447-E452.
40. Rousseau AF, Damas P, Janssens M, et al. Critical care and vitamin D status assessment: what about immunoassays and calculated free 25OH-D. Clin Chim Acta. 2014; 437: 43-47.
41. Powe CE, Ricciardi C, Berg AH, et al. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. Am Soc Bone Min Res. 2011; 26: 1609-1616.
42. Schwartz JB, Lai J, Lizaola B, et al. A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J Clin Endocrinol Metab. 2014; 99: 1631-1637.
43. 3 and parathyroid hormone reflect the 24-h profile in the critically ill? Intensive Care Med. 2012; 38: 177-179.
44. Piccione G, Assenza A, Grasso F, Caola G,. Daily rhythm of circulating fat soluble vitamin concentration (A,D, E and K) in the horse. J Circadian Rhythms. 2004; 2: 3.
45. Finamor DC, Sinigaglia-Coimbra R, Neves LC, et al. A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis. Dermatoendocrinology. 2013; 5: 222-234.
46. Ford ES, Ajani UA, McGuire LC, Liu S,. Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care. 2005; 28: 1228-1230.
47. Scragg R, Sowers MF, Bell C,. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey. Diabetes Care. 2004; 27 (12): 2813-2818.
48. Liu E, Meigs JB, Pittas AG, et al. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr. 2009; 139: 329-334.
49. 3 levels and cardiac function, dysglycemia, length of stay, and 30-d readmissions in cardiac surgery patients. Nutrition. 2015; 31 (6): 820-826.
50. Higgins DM, Wischmeyer PE, Queensland KM, Sillau SH, Sufit AJ, Heyland DK,. Relationship of vitamin D deficiency to clinical outcomes in critically ill patients. JPEN J Parenter Enteral Nutr. 2012; 36: 713-720.
51. Schuster I, Egger H, Bikle D, et al. Selective inhibition of vitamin D hydroxylases in human keratinocytes. Steroids. 2001; 66: 409-422.
52. Burkiewicz CJ, Guadagnin FA, Skare TL, do Nascimento MM, Servin SC, de Souza GD,. Vitamin D and skin repair: a prospective, double-blind and placebo controlled study in the healing of leg ulcers. Rev Col Bras Cir. 2012; 39: 401-407.
53. Cooke GL, Chien A, Brodsky A, Lee RC,. Incidence of hypertrophic scars among African Americans linked to vitamin D-3 metabolism? J Natl Med Assoc. 2005; 97: 1004-1009.
54. Yu D, Shang Y, Luo S, Hao L,. The Taq1 polymorphisms of VDR and the circulating 1,25-dihydroxyvitamin D levels confer the risk for the keloid scarring in Chinese cohorts. Cell Physiol Biochem. 2013; 32: 39-45.
55. Zhang GY, Cheng T, Luan Q, et al. Vitamin D: A novel therapeutic approach for keloid, an in vitro analysis. Br J Dermatol. 2011; 164: 729-737.
56. Hulshof MM, Bouwes Bavinck JN, Bergman W, et al. Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. J Am Acad Dermatol. 2000; 43: 1017-1023.
57. Toner CD, Davis CD, Milner JA,. The vitamin D and cancer conundrum: aiming at a moving target. J Am Diet Assoc. 2010; 110: 1492-1500.
58. Mayes T, Gottschlich MM, Scanlon J, Warden GD,. Four-year review of burns as an etiologic factor in the development of long bone fractures in pediatric patients. J Burn Care Rehabil. 2003; 24: 279-284.
59. Klein GL, Herndon DN, Goodman WG, et al. Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone. 1995; 17: 455-460.
60. Leblebici B, Sezgin N, Ulusan SN, Tarim AM, Akman MN, Haberal MA,. Bone loss during the acute stage following burn injury. J Burn Care Res. 2008; 29: 763-767.
61. Matsouka LY, Wortsman J, Haddad JG, Kolm P, Hollis BW,. Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol. 1991; 127: 536-538.
62. Willis CM, Laing EM, Hall DB, Hausman DB, Lewis RD,. A prospective analysis of plasma 25-hydroxyvitamin D concentrations in white and black prepubertal females in the southeastern United States. Am J Clin Nutr. 2007; 85: 124-130.
63. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR,. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002; 30: 771-777.